Register entry

Second Pharma Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
4
Labeller names
2
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Labelling1Packaging1particle size reduction1Relabelling1Repackaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Second Pharma Co., Ltd.No 33, Weiwu Road Hangzhou Gulf Fine Chemical Zone, Shangyu, Zhejiang 312369, China (CHN)Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging, particle size reduction, Relabelling, Repackaging3004836637527973171
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 bulk ingredient. By marketing category: BULK INGREDIENT 4.

Dosage formNDCs
powder4
RouteNDCs
Labeller name on the listingNDCs
second pharma co., ltd.3
second pharma co.,ltd.1
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
-Isoniazidpowder57845-1010BULK INGREDIENT
-Niacinamidepowder57845-1007BULK INGREDIENT
-Sulfamethazinepowder57845-1001BULK INGREDIENT
-valsartanpowder57845-1004BULK INGREDIENT
Compare

Comparable companies in China

Enquiry

Common questions

Is Second Pharma Co., Ltd. FDA approved?
Second Pharma Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Second Pharma Co., Ltd.'s drugs manufactured?
The FDA register lists Shangyu. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, packaging, particle size reduction, relabelling, repackaging.
What drugs does Second Pharma Co., Ltd. make?
4 products are listed under Second Pharma Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.